{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/RZV"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RZV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RZV\",,,,,undefined,":{"symbol":"RZV","market":"US","secType":"STK","nameCN":"Invesco S&P SmallCap 600 Pure Value ETF","latestPrice":102.1071,"timestamp":1750190400000,"preClose":103.2,"halted":0,"volume":2082,"hourTrading":{"tag":"盘后","latestPrice":102.1071,"preClose":102.1071,"latestTime":"16:04 EDT","volume":3,"amount":306.3213,"timestamp":1750190656066},"delay":0,"floatShares":1980040,"shares":1980040,"eps":3.47675,"marketStatus":"Post-Mkt","change":-1.0929,"latestTime":"06-17 18:20:45 EDT","open":102.02,"high":102.9,"low":102.02,"amount":212969.5644,"amplitude":0.008527,"askPrice":118.12,"askSize":100,"bidPrice":88.79,"bidSize":100,"shortable":3,"etf":1,"ttmEps":3.47675,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1750204800000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":103.2,"sharesOutstanding":1980040,"nav":101.15258,"aum":200286154.5032,"dividendRate":0.014299,"bidAskSpread":0.002523,"postHourTrading":{"tag":"盘后","latestPrice":102.1071,"preClose":102.1071,"latestTime":"16:04 EDT","volume":3,"amount":306.3213,"timestamp":1750190656066},"volumeRatio":0.751299,"impliedVol":0.2394,"impliedVolPercentile":0.708},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RZV\",,,,,undefined,":{"symbol":"RZV","floatShares":1980040,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.751299,"shares":1980040,"dividePrice":1.46,"high":102.9,"amplitude":0.008527,"preClose":103.2,"low":102.02,"week52Low":81.43,"pbRate":"--","week52High":120.255,"institutionHeld":0,"latestPrice":102.1071,"eps":3.47675,"divideRate":0.014299,"volume":2082,"delay":0,"ttmEps":3.47675,"open":102.02,"prevYearClose":111.3662,"prevWeekClose":101.09,"prevMonthClose":98.588,"prevQuarterClose":98.85,"fiveDayClose":103.1936,"twentyDayClose":100.5396,"sixtyDayClose":100.0822},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/RZV\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RZV\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2505864709","title":"Dana's FY24 Preliminary Results Highlight Increased Margins Amid EV Demand Slowdown; Stock Jumps","url":"https://stock-news.laohu8.com/highlight/detail?id=2505864709","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505864709?lang=en_us&edition=fundamental","pubTime":"2025-01-24 23:29","pubTimestamp":1737732576,"startTime":"0","endTime":"0","summary":"Dana Incorporated reported FY24 preliminary results, with sales at $10.3 billion and adjusted EBITDA at $885 million. FY25 outlook includes sales of $9.5-10.0 billion, adjusted EBITDA of $925 million-$1.025 billion, and free cash flow of $175-275 million. The company plans to restructure its business segments and expects to sell the Off-Highway segment to unlock shareholder value and reduce leverage.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/01/43194166/danas-fy24-preliminary-results-highlight-increased-margins-amid-ev-demand-slowdown-stock-jumps","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4124","ACTV","DAN","RZV"],"gpt_icon":0},{"id":"2468307820","title":"GSK Announces Positive Topline Data on Co-Administration of AREXVY and SHINGRIX","url":"https://stock-news.laohu8.com/highlight/detail?id=2468307820","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468307820?lang=en_us&edition=fundamental","pubTime":"2024-09-18 19:00","pubTimestamp":1726657200,"startTime":"0","endTime":"0","summary":"Trial met primary endpoint, non-inferior immune response for both vaccines when co-administered compared with separate administration. These data advance the science of co-administration of recommended adult vaccines. Len Friedland, MD, Vice President of Scientific Affairs and Public Health, GSK, said: \"We are excited to share data on the coadministration of our RSV and shingles vaccines. Adult immunization offers immense individual and societal benefits and yet, vaccination rates for adults are often inadequate. With our co-administration studies, GSK is using its science and technology to help remove barriers to adult immunization, by potentially reducing the number of visits to the healthcare offices and pharmacies and ultimately help to get ahead of RSV and shingles.\". Both RSV and shingles pose significant health risks to older adults, and these risks only increase with age as the immune system declines. Immunocompromised individuals and those with certain underlying medical condi","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/0saZT1nZxtndBpE8lFQz.w--~B/aD0yNzE7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/9beef2edd36befae509ac7b6149578f9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/0saZT1nZxtndBpE8lFQz.w--~B/aD0yNzE7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/9beef2edd36befae509ac7b6149578f9"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gsk-announces-positive-topline-data-110000099.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CDC","AGEN","LU1829250122.USD","BK4139","GSK","BK4007","BK4532","BK4585","BK4588","RZV","GSK.UK"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RZV\",params:#limit:5,,,undefined,":[{"date":"2025-03-24","symbol":"RZV","amount":0.52245,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"Invesco S&P SmallCap 600 Pure Value ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-28"},{"date":"2024-12-23","symbol":"RZV","amount":0.31818,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"Invesco S&P SmallCap 600 Pure Value ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-27","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-27"},{"date":"2024-09-23","symbol":"RZV","amount":0.33169,"announcedDate":"2024-09-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-09-23","defaultRemindTime":1727098200000,"name":"Invesco S&P SmallCap 600 Pure Value ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-27","payableDate":"2024-09-23","currency":"USD","dateTimestamp":1727064000000,"payDate":"2024-09-27"},{"date":"2024-06-24","symbol":"RZV","amount":0.28886,"announcedDate":"2024-06-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-24","defaultRemindTime":1719235800000,"name":"Invesco S&P SmallCap 600 Pure Value ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-28","payableDate":"2024-06-24","currency":"USD","dateTimestamp":1719201600000,"payDate":"2024-06-28"},{"date":"2024-03-18","symbol":"RZV","amount":0.32779,"announcedDate":"2024-03-15","type":"dividend","market":"US","newRecordDate":"2024-03-19","defaultRemindTime":1710768600000,"name":"Invesco S&P SmallCap 600 Pure Value ETF","recordDate":"2024-03-22","payableDate":"2024-03-19","currency":"USD","dateTimestamp":1710734400000,"payDate":"2024-03-22"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RZV\",market:\"US\",,,undefined,":[{"executeDate":"2015-06-19","recordDate":"2015-06-23","paymentDate":"2015-06-30","value":0.123999,"currency":"USD"},{"executeDate":"2015-09-18","recordDate":"2015-09-22","paymentDate":"2015-09-30","value":0.120829,"currency":"USD"},{"executeDate":"2015-12-18","recordDate":"2015-12-22","paymentDate":"2015-12-31","value":0.09296,"currency":"USD"},{"executeDate":"2016-03-18","recordDate":"2016-03-22","paymentDate":"2016-03-31","value":0.101971,"currency":"USD"},{"executeDate":"2016-06-17","recordDate":"2016-06-21","paymentDate":"2016-06-30","value":0.095015,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RZV\",market:\"US\",delay:false,,,undefined,":{}}}